Business Information
The group's principal activities are to design, develop, manufacture, sell and service bioanalytical measurement systems for life sciences and drug discovery applications. It generates revenues from two products: life sciences products and drug discovery products. The life sciences products consist of maxline, metamorph, skatron and threshold product lines. The drug discovery product family includes systems that integrate detection, liquid handling and automation. Product lines included in the drug discovery family are ionworks, flipr, analyst and discovery-1 systems. The principal customers of the group include leading pharmaceutical and biotechnology companies as well as medical centers, universities, government research laboratories and other institutions throughout the world. The group has operations in the United Kingdom, Germany, Switzerland, Norway and Japan.
|
|
Name |
Title
|
Email
|
| John Mayberry | Chmn. | N/A | | Andrew Boorn | Pres. - MDS Analytical Technologies | N/A | | David Spaight | Pres. - MDS Pharma Services | N/A | | Steven West | Pres. - MDS Nordion | N/A | | Thomas Gernon | CIO | N/A |
|
|
Year |
Sales |
Net Income |
| 2005 | 181,215 | 15,896 | | 2004 | 148,529 | 17,233 | | 2003 | 115,581 | 7,742
|
|
| TO SEE COMPLETE RESULTS SUBSCRIBE NOW |
TO SEE COMPLETE RESULTS SUBSCRIBE NOW |
|
Click for more Executives |
|
|
